chartexchange

BGLC
BioNexus Gene Lab Corp Common stock
stockNASDAQ

At CloseNov 17, 2026 3:59:39 PM EST
0.74USD-9.756%(-0.08)13,532
Pre-marketNov 17, 2026 8:50:30 AM EST
0.7474USD-8.854%(-0.0726)
After-hoursNov 17, 2026 4:00:30 PM EST
0.7662USD+3.541%(+0.0262)
0.6400Bid0.9300Ask0.3000Spread

BGLC Financials

In Q2 FY 2026 (ended ), BioNexus Gene Lab Corp Common stock (BGLC) reported revenue of $76.16K, net income of −$286.45K, operating cash flow of −$422.49K, and assets of $8.73M (filed ).

Loading business breakdowns…